Polyethylenimine Linear (PEI, MW 40,000): Atomic Evidence for DNA Transfection in Molecular Biology

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer widely validated as an in vitro DNA transfection reagent, facilitating transient gene expression in mammalian cells with typical efficiencies between 60–80% in serum-containing media (APExBIO PEI K1029). PEI condenses DNA into positively charged complexes, enhancing cellular uptake via endocytosis (see mechanistic overview). Its performance is cell line-dependent, with robust results in HEK-293, HEK293T, CHO-K1, HepG2, and HeLa cells (scalability details). Compatible with serum, PEI Linear is suitable for applications ranging from 96-well plate assays to 100-liter bioreactor protein production. The product is supplied at 2.5 mg/mL and should be stored at -20°C for long-term stability (APExBIO).

Biological Rationale

DNA transfection is essential in molecular biology for introducing foreign genes into eukaryotic cells, enabling transient gene expression and recombinant protein production (Roach 2024). Polyethylenimine Linear (PEI, MW 40,000) is a synthetic polymer with a high density of amine groups, conferring a strong positive charge at physiological pH. This allows PEI to bind and condense negatively charged DNA, forming complexes suitable for cellular uptake (Atomic Evidence dossier). PEI-mediated transfection is applicable to a wide variety of mammalian cell lines, supporting both research and therapeutic protein production workflows. The robust performance of PEI in serum-containing environments distinguishes it from many other transfection reagents that require serum-free conditions (Advanced In Vitro Benchmarks).

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

PEI Linear operates by electrostatically binding to the phosphate backbone of DNA, neutralizing its negative charge and condensing it into nanoparticles typically 50–200 nm in diameter (dynamic light scattering, pH 7.4) (Roach 2024). The resulting DNA-PEI complexes possess a net positive surface charge (measured by zeta potential), which promotes binding to the negatively charged proteoglycans and sialic acid residues on the cell membrane. Cellular uptake occurs predominantly via clathrin-mediated endocytosis (Mechanistic Insight). Once inside the endosome, the "proton sponge effect" of PEI buffers endosomal acidification, leading to osmotic swelling and endosomal rupture, thereby releasing the DNA into the cytoplasm. These steps culminate in nuclear import and transient gene expression.

Evidence & Benchmarks

• PEI Linear (MW 40,000) enables transfection efficiencies of 60–80% in HEK-293 cells under optimized conditions (37°C, 5% CO₂, DMEM + 10% FBS, 2.5 mg/mL PEI, DNA:PEI ratio 1:3 w/w) (APExBIO datasheet).
• DNA-PEI complexes maintain particle sizes of 100–180 nm (dynamic light scattering at pH 7.4), with zeta potentials between +25 to +35 mV, supporting efficient cellular uptake (Roach 2024, Table 2).
• PEI-mediated transfection is compatible with serum up to 20% FBS, yielding comparable or superior protein expression to commercial lipid-based reagents (Advanced In Vitro Benchmarks).
• Transfection of CHO-K1 and HeLa cells with PEI Linear achieves consistent gene expression, with large-scale protocols supporting up to 100 L bioreactor applications (Scalability dossier).
• In mRNA nanoparticle delivery studies, PEI significantly improves nucleic acid payload encapsulation and cellular uptake, as confirmed by qPCR and fluorescence microscopy (Roach 2024, Fig. 3).

Applications, Limits & Misconceptions

Polyethylenimine Linear (PEI, MW 40,000) is primarily used for transient DNA transfection in mammalian cell lines, optimizing recombinant protein production and gene function studies. It is validated in workflows ranging from microplate (96-well) screening to large-scale bioreactor runs for therapeutic protein manufacturing (K1029 kit). PEI is also a preferred reagent in kidney-targeted mRNA nanoparticle research, where its ability to condense and protect nucleic acids is leveraged to enhance delivery efficiency (Roach 2024).

This article extends the mechanistic and practical guidance provided in Mechanistic Insight by focusing on atomic, citable performance metrics and clarifying compatibility boundaries for PEI-based transfection workflows.

Common Pitfalls or Misconceptions

• PEI is not suitable for in vivo systemic delivery: Due to toxicity and aggregation risks, PEI Linear is limited to in vitro or ex vivo applications (Atomic Evidence update).
• Not all cell lines respond equally: Transfection efficiency varies between cell types; primary cells and some suspension lines may require alternative reagents or further optimization.
• Overuse increases cytotoxicity: Excessive PEI concentrations (>5 μg/mL final) can cause membrane damage and reduce cell viability.
• Repeated freeze-thaw cycles degrade PEI: For optimal performance, store PEI at -20°C for long-term and 4°C for frequent use, avoiding freeze-thaw cycles (APExBIO storage guidance).
• PEI is not effective for stable transfection: It is optimized for transient gene expression; long-term genomic integration requires different strategies.

Workflow Integration & Parameters

PEI Linear is typically supplied at 2.5 mg/mL in 4 mL or 8 mL aliquots. For a standard 6-well plate transfection, a DNA:PEI ratio of 1:3 (w/w) is recommended, with 2 μg DNA and 6 μg PEI per well in serum-containing DMEM. DNA and PEI should be diluted separately in 150 mM NaCl or HEPES-buffered saline (pH 7.4), incubated at room temperature for 10–20 minutes to allow complex formation, and then added dropwise to cells at 70–90% confluency. Protein expression is typically assessed 24–72 hours post-transfection (APExBIO protocol).

This article clarifies the boundaries of PEI Linear's utility compared to previous reports on optimizing DNA transfection in mammalian cells, by focusing on atomic evidence for efficiency, compatibility, and process control.

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) remains a gold-standard transfection reagent for in vitro molecular biology research, enabling high, serum-compatible transfection efficiencies and supporting both small- and large-scale applications. APExBIO's K1029 product delivers reproducible results across major cell lines. While not suitable for in vivo systemic use, its performance and ease of use in cell-based workflows are well-established. Ongoing innovation in nanoparticle and gene delivery technologies may further expand its relevance, particularly in targeted nucleic acid therapeutics (Roach 2024).